Navigation Links
AcelRx Secures $40 Million Credit Facility with Hercules Technology Growth Capital
Date:12/19/2013

AcelRx has also announced positive top-line results for a Phase 2 trial for ARX-04, a product candidate for the treatment of moderate-to-severe acute pain in a medically supervised setting, funded through a grant from the U.S. Army Medical Research and Materiel Command. The company has two additional pain treatment product candidates, ARX-02 and ARX-03, which have completed Phase 2 clinical development. For additional information about AcelRx's clinical programs, please visit www.acelrx.com.

Forward Looking Statements

This press release contains forward-looking statements, including, but not limited to, statements related to AcelRx Pharmaceuticals' financial viability, the sufficiency of funds to support its clinical and development program and operations, planned or anticipated future clinical development of AcelRx Pharmaceuticals' product candidates, the therapeutic and commercial potential of Zalviso and the anticipated timing, therapeutic and commercial potential of other AcelRx product candidates, and statements related to future events under the credit facility with Hercules, including its ability to access the third tranche funds under such facility. These forward-looking statements are based on AcelRx's current expectations and inherently involve significant risks and uncertainties. AcelRx's actual results and the timing of events could differ materially from those anticipated in such forward-looking statements as a result of these risks and uncertainties, which include, without limitation, risks related to: AcelRx's ability to receive regulatory approval for Zalviso; any delays or inability to obtain and maintain regulatory approval of its product candidates, including Zalviso, in the United States and Europe; its ability to attract funding partners or collaborators with development, regulatory and commercialization expertise; its ability to obt
'/>"/>

SOURCE AcelRx Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. AcelRx Pharmaceuticals Presents ARX-04 Dose-Finding Phase 2 Study Data at Anesthesia Medical Conference
2. AcelRx Pharmaceuticals Adds New Board Member
3. Annual General Meeting Schedules, New Drug Applications, Positive Study Results, Conference Participations, and Secondary Offerings - Research Report on Mindray, AcelRx, Merrimack, ZELTIQ, and Clovis
4. AcelRx Pharmaceuticals to Present at the 25th Annual Piper Jaffray Healthcare Conference
5. AcelRx Pharmaceuticals Reports Third Quarter 2013 Financial Results
6. AcelRx Pharmaceuticals to Hold Third Quarter 2013 Financial Results Conference Call and Webcast on November 5, 2013
7. David H. Chung Joins AcelRx Pharmaceuticals as Chief Commercial Officer
8. AcelRx Pharmaceuticals to Present at the Stifel Healthcare Conference 2013
9. AcelRx Pharmaceuticals Reports Second Quarter 2013 Financial Results
10. AcelRx Pharmaceuticals to Present at Canaccord Genuity 33rd Annual Growth Conference
11. AcelRx Pharmaceuticals to Hold Second Quarter 2013 Financial Results Conference Call and Webcast on August 12, 2013
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/24/2015)... N.J. , April 24, 2015  IGI Laboratories, ... based specialty generic pharmaceutical company, announced the ... ET on Tuesday, April 28, 2015 to discuss the ... you to listen to the call by dialing 1-888-346-3479. ... 1-855-669-9657.  Participants should ask to be joined into the ...
(Date:4/24/2015)... 2015 Boston Scientific Corporation (NYSE: BSX ) ... Annual Healthcare Conference on May 6 in ... vice president and chief financial officer, and Susie Lisa ... question and answer session regarding the company with the host ... webcast of the presentation and question and answer session will ...
(Date:4/24/2015)... The National Institute of Allergy and ... of Health [NIH])  provided grants totaling more than ... development of diagnostic tests for antibiotic-resistant bacteria . ... health facilities , the NIAID and other government ... effective tests using alternative methods to traditional culturing.   ...
Breaking Medicine Technology:Boston Scientific To Participate In The Deutsche Bank 40th Annual Healthcare Conference 2Kalorama: NIAID Rewards HAI Innovators with Grants 2Kalorama: NIAID Rewards HAI Innovators with Grants 3Kalorama: NIAID Rewards HAI Innovators with Grants 4
... Primary Endpoint of the Trial to Be Clarified ... Arbios Systems, Inc.,(OTC Bulletin Board: ABOS) announced today ... U.S. Food and Drug Administration ("FDA") of,an Investigational ... for SEPET(TM), Arbios, extracorporeal (outside the body) artificial,liver ...
... Feb. 21 Accumetrics, Inc. a privately-held,medical device ... tests that,measure patient response to antiplatelet drugs, announced ... Series D financing. The syndicate was led by,Arnerich ... Also participating,in the round were previous investors: Essex ...
Cached Medicine Technology:Arbios Receives Conditional Approval from the FDA to Initiate Pivotal Clinical Trial for SEPET(TM) 2Arbios Receives Conditional Approval from the FDA to Initiate Pivotal Clinical Trial for SEPET(TM) 3Arbios Receives Conditional Approval from the FDA to Initiate Pivotal Clinical Trial for SEPET(TM) 4Accumetrics Announces $28.8 Million Financing and Initiation of Pivotal Clinical Trial 2
(Date:4/24/2015)... The 1975 have had an intense ... globe to theaters, festivals and TV performances. Now that they’ve ... their label, Dirty Hit Records, to provide clean drinking water ... launched Cadence & Cause website, this four-piece has ... and a signed photo card. Entries from this sweepstakes ...
(Date:4/24/2015)... The first step to transforming one’s ... For meditation and yoga teacher Stine Koppernæs, meditation and ... tools that allow her to experience more peace and ... a teacher since 2006, and through the years she ... being. , “I love sharing this way of finding ...
(Date:4/24/2015)... 24, 2015 Carinsurancequotesinfo.com has released a ... explaining how to qualify for auto insurance ... qualify for auto insurance online, without having to follow ... that single parents can reduce their auto insurance expenses. ... and properly explained. , Clients can now visit ...
(Date:4/24/2015)... (PRWEB) April 24, 2015 Integrative ... two key pathways: immunity and cognition. , A ... Glutathione, helps set ProThrivers™ Wellness Flavonoid Complex apart ... the combination of ingredients to support antioxidation versus ... It unites curcumin, green tea extract, Resveratrol, Alpha-Glycosyl ...
(Date:4/24/2015)... (PRWEB) April 24, 2015 “Kind,” “selfless,” ... were among the ways Denise Weiner described pediatric oncology ... cared for her daughter, Alexa, during her five-year battle ... resections, a bone marrow transplant and numerous experimental treatments, ... to visit Alexa when she was not in the ...
Breaking Medicine News(10 mins):Health News:Internationally Recognized British Indie Rock Outfit The 1975 Partner with Cadence & Cause to Provide Clean Drinking Water to Those in Need 2Health News:Auto Insurance Discounts for Single Parents - How to Qualify for Low Rates 2Health News:Integrative Therapeutics Introduces Two ProThrivers™ Wellness Supplements with Specialty Ingredients from Kyowa Hakko USA 2Health News:Integrative Therapeutics Introduces Two ProThrivers™ Wellness Supplements with Specialty Ingredients from Kyowa Hakko USA 3Health News:Integrative Therapeutics Introduces Two ProThrivers™ Wellness Supplements with Specialty Ingredients from Kyowa Hakko USA 4Health News:CURE™ Magazine Names Pediatric Nurse Laura Vasquez from Children’s Hospital Los Angeles As Extraordinary Healer™ of 2015 2Health News:CURE™ Magazine Names Pediatric Nurse Laura Vasquez from Children’s Hospital Los Angeles As Extraordinary Healer™ of 2015 3Health News:CURE™ Magazine Names Pediatric Nurse Laura Vasquez from Children’s Hospital Los Angeles As Extraordinary Healer™ of 2015 4
... (HealthDay News) -- Children who are successfully treated for ... severe gastrointestinal problems down the road, a new study ... Francisco analyzed the self-reported gastrointestinal (GI) problems of 14,358 ... for cancers such as lymphoma, leukemia, brain tumors or ...
... from the National Institutes of Health (NIH) to help ... shown effective in mice toward clinical trials in humans. ... Sanfilippo Syndrome B, is a lysososmal storage disease caused ... MPS IIIB appear normal at birth, but develop severe, ...
... number of cases of adenocarcinoma of the esophagus (or gullet) ... new ways of treatment are improving the outlook for patients. ... ( Dtsch Artzebl Int 2011; 108[18]: 313𔃇), Angelika Behrens ... treatment. The main cause of this cancer is reflux ...
... led by Trinity College Dublin that aims ... been selected for grant funding of 6 million by ... consortium NILVAD*, comprising 18 European universities, hospitals and pharmaceutical ... the treatment of Alzheimer,s disease (AD). Trinity ...
... be older, better-educated and divorced, widowed or separated, research ... University of Nottingham found that emotional factors and mental ... by women. And they also discovered that rehabilitation ... their crime can intensify their feelings of guilt and ...
... gut flora is believed to trigger obesity. In the same way, ... be the case in tests on rats. Daily intake ... Lactobacillus plantarum HEAL19, appears to be able to prevent ... were given this specific lactic acid bacterium from their time in ...
Cached Medicine News:Health News:Childhood Cancer Therapies Tied to Gastrointestinal Issues 2Health News:NIH grant for the move toward clinical trials targeting the lysosomal storage disease MPSIIIB 2Health News:Clinical trials for new Alzheimer's disease treatment to be awarded European Commission €6m funding 2Health News:Research study reveals profile for female drunk-drivers 2Health News:Research study reveals profile for female drunk-drivers 3Health News:Healthy gut flora could prevent obesity 2
Minimizes imperfections and reduces the visible appearance of cellulite and stretch marks. This formula refines uneven skin texture and improves skin firmness and elasticity to leave you with skin yo...
The fat loss formula's key ingredient of 2.0% aminophylline works by penetrating deep into the skin where it causes the body fat cells to shrink, resulting in up to 2 inches of body fat loss....
... This new Suction Massage System has ... prone areas, such as thighs, buttocks and ... massaging the lymph system, mobilizing excess fluids ... naturally. Initially, we recommend using CELLUSSAGE daily, ...
... the first and only class ... revolutionary elos combined energy technology ... Infrared Light plus tissue ... reduce the appearance of cellulite ...
Medicine Products: